Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Hany Zayed's publication output changed over time?
ScholarIQpublication output · 2009–2024
Output grew0% over the shown period — from 1 works in 2009 to 1 in 2024.
1
2
2
1
1
1
1
2
1
200920122013201620172018201920232024
What are the most-cited papers on Hany Zayed?
ScholarIQmost cited works
Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study
Charles M. Rudin, M. Catherine Pietanza, Todd M. Bauer, Neal Ready, Daniel Morgensztern, Bonnie S. Glisson, Lauren A. Byers, Melissa L. Johnson, Howard A. Burris, Francisco Robert, Tae Hyung Han, Sheila Bheddah, Noah Theiss, Sky Watson, Deepan Mathur, Bharathi Vennapusa, Hany Zayed, Satwant Lally, Donald K. Strickland, Ramaswamy Govindan, Scott J. Dylla, Stanford L. Peng, David R. Spigel
The Lancet Oncology. 2016563 CitationsOPEN ACCESS
A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion (BASIL-2): an open-label, randomised, multicentre, phase 3 trial
Andrew W. Bradbury, Catherine A Moakes, Matthew Popplewell, Lewis Meecham, Gareth Bate, Lisa Kelly, Ian Chetter, Αθανάσιος Διαμαντόπουλος, Arul Ganeshan, Jack Hall, Simon Hobbs, Kim Christian Houlind, Hugh Jarrett, Suzanne Lockyer, Jonas Malmstedt, Jai V. Patel, Smitaa Patel, S. Tawqeer Rashid, Athanasios Saratzis, Gemma Slinn, D. Scott, Hany Zayed, Jonathan J Deeks
The Lancet. 2023407 CitationsOPEN ACCESS
Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo‐controlled trials
James B. Bussel, Donald M. Arnold, Elliot Grossbard, Jiřı́ Mayer, Jacek Treliński, Wojciech Homenda, Andrzej Hellmann, Jerzy Windyga, Liliya Sivcheva, Alhossain A. Khalafallah, Francesco Zaja, Nichola Cooper, Vadim Markovtsov, Hany Zayed, Anne‐Marie Duliège
American Journal of Hematology. 2018359 CitationsOPEN ACCESS
Effects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes
Claudia Cavelti‐Weder, Andrea Babians-Brunner, Cornelia Keller, Marc Stahel, M. Kurz–Levin, Hany Zayed, Alan M. Solinger, Thomas Mandrup‐Poulsen, Charles A. Dinarello, Marc Y. Donath
Diabetes Care. 2012309 CitationsOPEN ACCESS
The impact of arterial pedal arch quality and angiosome revascularization on foot tissue loss healing and infrapopliteal bypass outcome
Hisham Rashid, Hani Slim, Hany Zayed, Dean Y. Huang, C. Jason Wilkins, David Evans, Paul S. Sidhu, Michael Edmonds
Journal of Vascular Surgery. 2013152 CitationsOPEN ACCESS
Related on ScholarIQ
Guy's and St Thomas' NHS Foundation Trust
Institution
Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study
Paper
A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion (BASIL-2): an open-label, randomised, multicentre, phase 3 trial
Paper
Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo‐controlled trials
Paper
Effects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes
Paper
The impact of arterial pedal arch quality and angiosome revascularization on foot tissue loss healing and infrapopliteal bypass outcome
Paper